Resultados da pesquisa - Mohamed Abou‐El‐Enein

  • A mostrar 1 - 19 resultados de 19
Refinar resultados
  1. 1
    Overcoming Challenges Facing Advanced Therapies in the EU Market

    Overcoming Challenges Facing Advanced Therapies in the EU Market Por Mohamed Abou‐El‐Enein, Ahmed Elsanhoury, Petra Reinke

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions

    Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions Por Gerhard Bauer, Magdi Elsallab, Mohamed Abou‐El‐Enein

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Unproven stem cell interventions: A global public health problem requiring global deliberation

    Unproven stem cell interventions: A global public health problem requiring global deliberation Por Zubin Master, Kirstin R.W. Matthews, Mohamed Abou‐El‐Enein

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy

    Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy Por Enrico Fritsche, Hans‐Dieter Volk, Petra Reinke, Mohamed Abou‐El‐Enein

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    CAR T-cell product performance in haematological malignancies before and after marketing authorisation

    CAR T-cell product performance in haematological malignancies before and after marketing authorisation Por Magdi Elsallab, Bruce L. Levine, Alan S. Wayne, Mohamed Abou‐El‐Enein

    Publicado em 2020
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals

    Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals Por Magdi Elsallab, Christopher A. Bravery, Armin Kurtz, Mohamed Abou‐El‐Enein

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Putting a price tag on novel autologous cellular therapies

    Putting a price tag on novel autologous cellular therapies Por Mohamed Abou‐El‐Enein, Gerhard Bauer, Nicholas Medcalf, Hans‐Dieter Volk, Petra Reinke

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Por Jee H. Choe, Hisham Abdel‐Azim, William V. Padula, Mohamed Abou‐El‐Enein

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis

    Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis Por Magdi Elsallab, Moataz Ellithi, Susanne Hempel, Hisham Abdel‐Azim, Mohamed Abou‐El‐Enein

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  10. 10
    High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing

    High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing Por Amaia Cadiñanos-Garai, Christian Flugel, Anson Cheung, Enzi Jiang, Alix Vaissié, Mohamed Abou‐El‐Enein

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

    Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours Por Christian Flugel, Robbie G. Majzner, Giedre Krenciute, Gianpietro Dotti, Stanley R. Riddell, Dimitrios L. Wagner, Mohamed Abou‐El‐Enein

    Publicado em 2022
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  12. 12
    Telbivudine in chronic lymphocytic myocarditis and human parvovirus <scp>B19</scp> transcriptional activity

    Telbivudine in chronic lymphocytic myocarditis and human parvovirus <scp>B19</scp> transcriptional activity Por Sophie Van Linthout, Ahmed Elsanhoury, Oliver Klein, Marzena Sosnowski, Kapka Miteva, Dirk Laßner, Mohamed Abou‐El‐Enein, Burkert Pieske, Uwe Kühl, Carsten Tschöpe

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Non-viral chimeric antigen receptor (CAR) T cells going viral

    Non-viral chimeric antigen receptor (CAR) T cells going viral Por Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai, Christabel E. Fowler, Nikolaos Gkitsas, Annie Kathleen Brown, Ramya Tunuguntla, Mohamed Abou‐El‐Enein, S. Feldman

    Publicado em 2023
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  14. 14
    Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

    Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy Por Mohamed Abou‐El‐Enein, Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks, Brian G. Till, Gerhard Bauer, Barbara Savoldo

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  15. 15
    Immunogenicity of CAR T cells in cancer therapy

    Immunogenicity of CAR T cells in cancer therapy Por Dimitrios L. Wagner, Enrico Fritsche, Michael A. Pulsipher, Nabil Ahmed, Mohamad Hamieh, Meenakshi Hegde, Marco Ruella, Barbara Savoldo, Nirali N. Shah, Cameron J. Turtle, Alan S. Wayne, Mohamed Abou‐El‐Enein

    Publicado em 2021
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  16. 16
    Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD

    Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD Por Sybille Landwehr-Kenzel, Leonie Müller‐Jensen, Joern-Sven Kuehl, Mohamed Abou‐El‐Enein, Henrike Hoffmann, Sandra Muench, Daniel R. Kaiser, Andy Roemhild, Horst von Bernuth, Mirjam Voeller, Michael Schmueck‐Henneresse, Bernd Gruhn, Ulrik Stervbo, Nina Babel, Hans‐Dieter Volk, Petra Reinke

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial

    Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial Por Andy Roemhild, Natalie Otto, Guido Moll, Mohamed Abou‐El‐Enein, Daniel R. Kaiser, Gantuja Bold, Thomas Schachtner, Mira Choi, Robert Oellinger, Sybille Landwehr-Kenzel, Karsten Juerchott, Birgit Sawitzki, Cordula Giesler, Anett Sefrin, Carola Beier, Dimitrios L. Wagner, Stephan Schlickeiser, Mathias Streitz, Michael Schmueck‐Henneresse, Leila Amini, Ulrik Stervbo, Nina Babel, Hans‐Dieter Volk, Petra Reinke

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Integration of <i>ζ</i>-deficient CARs into the <i>CD3</i> <i>ζ</i> gene conveys potent cytotoxicity in T and NK cells

    Integration of <i>ζ</i>-deficient CARs into the <i>CD3</i> <i>ζ</i> gene conveys potent cytotoxicity in T and NK cells Por Jonas Kath, Clemens Franke, Vanessa Drosdek, Weijie Du, Viktor Glaser, Carla Fuster‐García, Maik Stein, Tatiana Zittel, Sarah Schulenberg, Caroline E. Porter, Lena Andersch, Annette Künkele, Joshua Alcaniz, Jens Hoffmann, Hinrich Abken, Mohamed Abou‐El‐Enein, Axel Pruß, Masataka Suzuki, Toni Cathomen, Renata Stripecke, Hans‐Dieter Volk, Petra Reinke, Michael Schmueck‐Henneresse, Dimitrios L. Wagner

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++

    COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++ Por Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez‐Navarro, Adrian Doevelaar, Felix S. Seibert, Bodo Hölzer, Sarah Skrzypczyk, Eva Kohut, Julia Kurek, Jan Zapka, Patrizia Wehler, Sviatlana Kaliszczyk, Sharon Bajda, Constantin J. Thieme, Toralf Roch, Margarethe Konik, Marc Moritz Berger, Thorsten Brenner, Uwe Kölsch, Toni Luise Meister, Stephanie Pfaender, Eike Steinmann, Clemens Tempfer, Carsten Watzl, Sebastian Dolff, Ulf Dittmer, Mohamed Abou‐El‐Enein, Timm H. Westhoff, Oliver Witzke, Ulrik Stervbo, Nina Babel

    Publicado em 2020
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: